Danaher Corporation SEC Filings

Danaher (DHR): A selling securityholder filed a Form 144 notice to sell up to 21,776 shares of Danaher common stock. The filing lists an aggregate market value of $4,773,863.62, with an approximate sale date of 11/12/2025. The planned sales are through Fidelity Brokerage Services LLC on the NYSE.

The shares were acquired via an option granted on 02/24/2016, with payment listed as cash on 11/12/2025. This notice reflects an intention to sell under Rule 144 and does not itself complete a transaction.

A Form 144 notice discloses a proposed sale of 16,172 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $3,470,831.41. The planned sale is listed for the NYSE on or about 11/11/2025.

The seller acquired the shares via an option granted on 11/15/2015 and paid cash on 11/11/2025. Shares outstanding were 706,349,563.

Danaher (DHR) — Form 144 notice of proposed sale. A company affiliate filed to sell 5,174 shares of Danaher common stock on or after 11/10/2025 on the NYSE through Fidelity Brokerage Services LLC. The filing lists an aggregate market value of $1,088,703.60 for the proposed sale.

The shares derive from multiple acquisitions: 403 shares vested on 02/24/2025, 255 on 03/01/2025, 340 on 05/15/2025 (all as restricted stock vesting/compensation), and 4,176 shares from options granted 02/24/2018 and exercised for cash on 11/10/2025.

Shares outstanding were 706,349,563; this is a baseline figure, not the amount being sold. The signer represents they do not know of undisclosed material adverse information regarding the issuer’s operations.

Danaher (DHR) announced a planned Board change. Director John T. Schwieters will not stand for reelection at the 2026 annual meeting and will retire at that time. The company stated his decision was not due to any disagreement on operations, policies, or practices.

Following his retirement, the Board size will be reduced from thirteen to twelve members. This is a governance update with no operational or financial changes disclosed.

Danaher (DHR) insider Mitchell P. Rales reported stock sales on a Form 4. On 10/31/2025, he sold a total of 600,000 shares of common stock in three transactions at weighted average prices of $215.67, $216.26, and $217.17. He is listed as a Director and Officer (Chairman of Exec. Committee).

Following these sales, Rales directly owned 990,228 shares. Indirect holdings listed include 912,654 shares through the Mitchell P. Rales Family Trust, 25,671,000 shares through single-member LLCs, and 667 shares via a 401(k) plan. The filing also lists 3,256 shares held by a trust for his daughter, with Rales disclaiming beneficial ownership of those shares. Price ranges for the sales were disclosed as $215.00–$215.99, $216.00–$216.99, and $217.00–$217.66.

Danaher (DHR) reported a Form 4 for director Feroz Dewan.

On 10/31/2025, the reporting person acquired 153.431 phantom shares under the Non‑Employee Directors Deferred Compensation Plan at a reference price of $215.38. Following the acquisition, 1,859.516 derivative securities were beneficially owned, held directly. Phantom shares convert into common stock on a one‑for‑one basis upon distribution, and the amounts are fully vested.

Danaher (DHR) director Alan G. Spoon reported a routine equity compensation transaction. On 10/31/2025, he acquired 195.724 phantom shares under the Non‑Employee Directors Deferred Compensation Plan, tied to a reference closing price of $215.38. Following the transaction, he beneficially owned 30,367.495 derivative (phantom) shares, held directly.

Per the plan, phantom shares reflect deferred director fees and convert into Danaher common stock on a one‑for‑one basis upon distribution. The derivative shows a $0 conversion/exercise price, consistent with fee deferrals rather than an option grant.

Danaher Corporation reported a director’s Form 4 showing the acquisition of 160.891 phantom shares on 10/31/2025 under the Non-Employee Directors Deferred Compensation Plan. The plan converts deferred director fees (including dividend accruals) into notional shares using the NYSE closing price on the transaction date, listed as $215.38.

The phantom shares convert into common stock on a one-for-one basis upon distribution, and the reporting person is fully vested in amounts deferred. Following the transaction, 6,888.48 derivative securities were beneficially owned.

Danaher (DHR) director Elias A. Zerhouni reported a routine deferred‑compensation transaction. On 10/31/2025, he acquired 203.472 phantom shares under the Non‑Employee Directors Deferred Compensation Plan, reflecting quarterly fee deferral.

The Plan converts deferred amounts into notional Danaher shares using the NYSE closing price; the filing lists $215.38 as the reference price. Phantom shares convert into common stock on a one‑for‑one basis upon distribution. Following this transaction, he beneficially owns 18,012.058 derivative securities, held directly.